MenopauseTalk

Is Hormone Replacement Therapy Being Applied Too Uniformly?

Menopause care has advanced. Awareness is higher. Prescriptions are rising. Yet many women still report inconsistent results from HRT, limited follow-up and uncertainty about whether their treatment is truly personalised.

In 'Beyond One-Size HRT', we examine a critical question in modern women’s health:

Are we still applying a standardised hormone therapy model to biologically diverse women?

Leading authourities including the North American Menopause Society, NICE and the British Menopause Society are clear. Hormone replacement therapy should be individualised based on age, timing since menopause, cardiovascular risk, symptom profile and medical history.

Have We Underestimated What Menopause Really Is?

For years, menopause has been reduced to two headline symptoms. Hot flushes and mood swings. Yet clinical research tells a far more complex story. In the United Kingdom alone, over 13 million women are peri- or post-menopausal.

Globally, nearly 85 percent of women experience symptoms that affect daily life, work performance, sleep, relationships, cognition and physical health.

Still, many women are left wondering “Is this really menopause… or is something wrong with me?”

Getting HRT:

Understanding Your Options and Knowing How Long to Stay On It!

Menopause Is Not the Problem. Being Denied Care Is.

Menopause is already a profound physiological and psychological transition. Hormones shift, sleep fractures, cognition feels unreliable, emotions intensify, joints ache, confidence wobbles. Yet for Black and South Asian women, menopause is rarely permitted to exist as a legitimate medical event. It is filtered instead through disbelief, misinterpretation and systemic minimisation.

The data now confirms what women have been saying quietly for years. Analysis of prescription records covering 1.85 million women in the UK shows that while 23.3 percent of white women are prescribed Hormone Replacement Therapy, only around 5 to 5.2 percent of Black women and 6 to 6.2 percent of Asian women receive the same treatment.

Lupus and Menopause:

When Two “Invisible” Health Journeys Collide!

Lupus is often spoken about as a “rare” condition, yet the numbers tell a different story when you look closely at who is most affected and when symptoms peak. In the United States, more than 200,000 people are estimated to have systemic lupus erythematosus (SLE) and women make up the overwhelming majority of cases. In the United Kingdom, large-scale primary care data show SLE incidence around 5.47 per 100,000 person-years and prevalence has risen over time.

Now layer menopause on top. The midlife transition that already carries its own burden of disrupted sleep, joint pain, mood changes, brain fog and rising cardiovascular risk. For women living with lupus, menopause is not simply “a phase”. It can be a turning point that changes symptom patterns, complicates treatment choices and exposes health inequities that have been present all along.

Understanding the Disproportionate Impact of…

Equity in Menopause Care

Menopause is often discussed as a universal biological transition. In practice, it is anything but universal. Who is believed, who is treated early and who gains access to specialist care is shaped as much by systems, culture and confidence as it is by hormones.

Across health systems, menopause inequity does not show up loudly. It appears quietly, in delayed diagnoses, inconsistent prescribing, postcode lotteries and women being told to “wait it out” when evidence says otherwise. These gaps matter most for women whose voices have historically been marginalised.

Recent policy and clinical developments have brought these inequities into sharper focus.

In England, menopause has now been confirmed as a priority condition within the forthcoming NHS Online Hospital, enabling women to be referred digitally for specialist menopause care via the NHS App. This shift has the potential to reduce regional disparities, long waiting times and barriers faced by…

Why Do Women Link Menopause and Dementia?

Many women notice memory lapses, brain fog or difficulty concentrating during menopause and wonder “Is this dementia?”

Here’s what the evidence actually shows.

Sexual Health in Menopause:

What the Pandemic Revealed and Why Women of Colour Need a Different Conversation

During perimenopause and menopause, many women experience changes they were never fully prepared for. Lower sexual desire, vaginal dryness, difficulty with arousal and, for some, painful intercourse.

These shifts are driven primarily by declining estrogen and testosterone, but the emotional impact often runs deeper than the biology.

Hormone therapy can help, but research consistently shows its effects on sexual function are modest. Pleasure, intimacy and desire are shaped not only by hormones, but by stress, relationship dynamics, cultural expectations and emotional wellbeing. So, when the pandemic hit, those layers became even more complicated.

HRT Black Box Warning Removed: 

 What Women Need to Know  

What Happened? 

The FDA recently removed the black box warning from most Hormone Replacement Therapy (HRT) products. This warning, introduced in 2003 after the Women’s Health Initiative (WHI) study, highlighted risks like breast cancer and heart disease.